A case of triphenyltin acetate (TPTA) poisoning is described. The patient, who had been exposed mainly to cutaneous absorption, showed acute stages of an urticarial eruption, signs of hepatic injury, slight glucose intolerance, and electroencephalographic abnormalities. Concomitant with the highest concentrations of tin in plasma and the peak of tin excretion in urine, neutrophils did not show the normal increase in actin polymerisation after stimulation with a chemotactic peptide (100 nM fMLP). The peak of urinary excretion of tin occurred between the fifth and the sixth day after poisoning; subsequently, the rate of excretion became slow, suggesting biphasic kinetics with the possiblity of a cumulative trend.
Triphenyltin acetate (TPTA) belongs to the group of organotin compounds used world wide as biocides. In Italy 500 000 Kg of organotin compounds were used in 1984.' Triphenyltin acetate is used as a molluscicide, an antifouling agent, a fungicide, and a rodent repellant.2 About 25 years ago, a mixture of organotin compounds used for the treatment of boils, osteomyelitis, anthrax, and acne poisoned at least 217 people, of whom 100 died. 3 The most common clinical picture was characterised by impairment of the central nervous system (CNS) with interstitial oedema of the white matter. 3 Cases of intoxication due to occupational exposure have also been published. The main route of absorption seems to be the respiratory tract. Some degree of cutaneous absorption, however, cannot be excluded. " Case history The patient, a man aged 36, was accidentally exposed to an unknown amount of 18-95% formulation TPTA (Brestan).
He was handling a package of the compound without gloves and spilt the pesticide powder on the exposed cutaneous area of his arms. He washed immediately but about 12 hours later experienced bilateral plantar pain and, after around 24 hours, severe genital oedema. Some hours later an erythematous eruption appeared on his trunk (see fig 1) . In the past he had had similar accidents with TPTA without reporting any adverse effects on his health. Two days after the accident, the patient had general malaise, dizziness, nausea, and abdominal pain for which he was admitted to hospital.
On admission, temperature, pulse rate, and blood pressure were normal; physical examination showed slight genital oedema, urticarial eruptions on his trunk, and pronounced hepatomegaly (lower liver margin about 5 cm below the costal margin). Blood glucose concentration was 113 mg/100 ml (normal value 60-110), y-glutamyl transpeptidase (y-GT) 68 IU/1, and bilirubin 1 52 mg/100 ml (normal value 0 36). Other routine laboratory findings were normal. A glucose tolerance test on the fifth day showed impairment of glucose metabolism and slight glycosuria.
The day after admission to hospital, activity of serum transaminases was high (AST 76 Subsequently, the rate of excretion decreased; one month after the poisoning a urinary concentration of 28 ,g/l was found. This was still higher than the tin concentration in the urine sample taken two days after the poisoning (18 yg/l).
Reference values are not available but in our experience values range from six to 30 pg/l in nonexposed subjects. Tin disappeared rapidly from the plasma, most being lost between the second and fourth day concomitant with the increase in urinary excretion. A second, small peak in tin concentration in blood was found on the sixth day (fig 2) . On the fourth day, the PMNs did not show any increase in actin polymerisation in comparison with PMNs of healthy human subjects (p < 0-01); on the eighth day, the PMNs had recovered somewhat, although their activity was still lower than that of healthy human subjects (p < 0-01). Activity of PMNs was normal by 16 days after the accident (fig 2) .
Discussion
The patient showed usual signs of organotin poisoning-namely, dizziness, nausea, possible impairment of the central nervous system, and liver damage.
Our clinical findings seem to confirm results obtained in animals indicating that TPTA is less neurotoxic than other organotin compounds as the patient showed only electroencephalographic anomalies with no clinical evidence of impairment of the CNS. The bilateral plantar pain suffered 12 hours after the poisoning could be a sign of slight impairment of the peripheral nervous system.
Other organotin compounds-for example, tributyl and dibutylin-cause cutaneous erythema due to an irritative effect8; the patient under study did not show any such effect. The severe genital oedema and the urticarial eruption with an increase in circulating IgE, which persisted in spite of steroid treatment and without exposure to TPTA, have not previously been described as associated with organotin poisoning. On the basis of the history of the patient we believe we can attribute these findings to TPTA poisoning. The lack of evidence of cutaneous sensitisation to the components of the product may be due to the presence of unknown metabolites acting as antigens; the persistence of urticarial eruptions could be interpreted as a chronic urticaria caused by the unknown antigen(s) and not depending on a mechanism belonging to the first group of Gell and Coomb's classification.
The mechanism by which the liver is damaged by organotin compounds is still not clear; some authors have postulated an impairment of the hepatic transport mechanism or the conjugation of bilirubin with glutathione, or both.5 In our case the concentration of serum bile acid, measured to evaluate possible impairment of the hepatic transport mechanism,"0 remained normal.
It is interesting that PMN activity seems to be impaired by TPTA. At the time of the peak of urinary tin excretion, the patient's PMNs did not show the normal actin polymerisation in response to a stimulus. They had partly recovered by eight days and had returned to normal 16 days after poisoning. These data seem to confirm the findings of a decrease in the amount of the polymerised form of actin (Factin), the main component of microfilaments, found in laboratory studies. '6 The determination of tin in blood and urine showed an abnormally high concentration of tin. The rates of urinary excretion and disappearance from blood indicate biphasic kinetics, and suggest the possibility of a cumulative action. No data on the metabolic fate of TPTA in man are available and the toxicological significance of these findings is still unclear. Our findings imply that TPTA can penetrate the unbroken skin; a degree of respiratory absorption, however, cannot be excluded.
